Home LiteratureArticle Details
PMID: 3003345 Published · ppublish English Journal Article

Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity.

The Journal of pharmacology and experimental therapeutics ·Vol. 236 ·No. 2 ·1986-02-00 ·Pages 476-80

Mansour H, Levacher M, Gougerot-Pocidalo MA, Rouveix B, Pocidalo JJ

Abstract

Prolonged exposure of C57B16 mice to pure O2 at 1 ATA induced pulmonary edema associated with involution of lymphoid system and depressed immunity. The consequences of these toxic events were evaluated by 1) mortality rate, 2) determination of pulmonary water, 3) thymic and splenic cellularity, and 4) humoral (primary antibodies) and cellular (mitogenic) immune responses. Pretreatment of mice with 125 mg kg-1 of diethyldithiocarbamate (DDC) several days before exposure to O2 resulted in 1) an increase in animal survival (92-100% vs. 59% O2 controls), 2) a reduction in pulmonary edema, 3) partial stabilization of thymus and spleen lymphocyte populations, and 4) restoration of the humoral response (specific antibodies appeared earlier than in O2 control animals) and improvement of the mitogenic proliferative response of the spleen cells after hyperoxia. None of these effects were observed when DDC treatment coincided with the beginning of exposure. Our results indicated that DDC protects mice from both pulmonary and lymphoid hyperoxic injury, but only in a partial manner. It is suggested that the mechanism of this antioxidative property is indirect.

MeSH Terms
Animals Antibody Formation/drug effects Cell Count Ditiocarb/pharmacology Female Glutathione/metabolism Lung/drug effects Lymphoid Tissue/drug effects Mice Mice, Inbred C57BL Mitogens/pharmacology Oxygen/toxicity Pulmonary Edema/chemically induced Thiocarbamates/pharmacology
Chemicals
Mitogens Thiocarbamates Ditiocarb Glutathione Oxygen
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Mansour H
Levacher M
Gougerot-Pocidalo M A
Rouveix B
Pocidalo J J
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1986-02-00
Pages
476-80
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com